What is the recommended dosage and frequency of Nitrofurantoin (antibiotic) tablets for treating urinary tract infections (UTIs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nitrofurantoin Dosage and Frequency for Urinary Tract Infections

For uncomplicated urinary tract infections (UTIs), nitrofurantoin should be dosed at 100 mg orally every 6 hours for treatment of UTIs due to vancomycin-resistant Enterococcus (VRE), or 100 mg twice daily for 5-7 days for standard uncomplicated UTIs. 1

Dosing Recommendations by Indication

Uncomplicated UTIs in Women

  • Nitrofurantoin monohydrate/macrocrystals: 100 mg orally twice daily for 5-7 days 1
    • Clinical efficacy rate: 93% (range 84-95%)
    • Microbiological efficacy rate: 88% (range 86-92%)
    • Common side effects: nausea, headache

UTIs due to Vancomycin-Resistant Enterococcus (VRE)

  • Nitrofurantoin: 100 mg orally every 6 hours 1
    • Recommended with weak recommendation, very low quality of evidence
    • Alternative options for VRE UTIs include:
      • Single dose of fosfomycin 3 g orally 1, 2
      • High-dose ampicillin (18-30 g IV daily in divided doses) or amoxicillin 500 mg orally/IV every 8 hours 1

Evidence for Efficacy

  • Randomized controlled trials have demonstrated that nitrofurantoin is significantly more effective than placebo in achieving both symptomatic relief and bacteriological cure 3

    • After 3 days: 27/35 combined symptomatic improvement/cure with nitrofurantoin vs. 19/35 with placebo
    • Bacteriological cure after 3 days: 21/26 with nitrofurantoin vs. 5/25 with placebo
  • Nitrofurantoin (100 mg twice daily for 5 days) has shown equivalent clinical and microbiological cure rates to trimethoprim-sulfamethoxazole (160/800 mg twice daily for 3 days) 1

  • In a study comparing nitrofurantoin (50 mg four times daily for 7 days) with single-dose fosfomycin (3 g), clinical and bacteriological cure rates were not significantly different, though more early side effects were reported with fosfomycin 4

Pediatric Dosing

  • For children: 5-7 mg/kg/day orally in 4 divided doses 1
  • Maximum dose: 100 mg per dose 1

Important Clinical Considerations

  • Nitrofurantoin is not recommended for pyelonephritis or perinephric abscess 1
  • Recommended treatment duration is 7 days or at least 3 days after obtaining a sterile urine 1
  • Recent UK guidelines recommend 3-day courses of nitrofurantoin (100 mg twice daily), though evidence directly supporting this shorter duration is limited 5
  • Nitrofurantoin should be taken with food to improve absorption and reduce gastrointestinal side effects 6

Monitoring and Follow-up

  • Clinical response should be expected within 3 days of treatment initiation 3
  • If symptoms persist beyond 3 days, consider alternative diagnosis or resistant organism 1
  • Routine post-treatment urinalysis or urine cultures are not indicated for asymptomatic patients 2

Contraindications

  • Not recommended in patients with creatinine clearance <30 mL/min 7
  • Use with caution in patients with G6PD deficiency due to risk of hemolysis 7
  • Not recommended for use in the last trimester of pregnancy due to risk of hemolytic anemia in the newborn 7

Nitrofurantoin remains an important first-line agent for uncomplicated UTIs due to its continued effectiveness against most uropathogens and low rates of resistance development 6, 7.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Fosfomycin Treatment for Uncomplicated Urinary Tract Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women.

The British journal of general practice : the journal of the Royal College of General Practitioners, 2002

Research

Nitrofurantoin: what is the evidence for current UK guidance?

The Journal of antimicrobial chemotherapy, 2023

Research

Optimizing dosing of nitrofurantoin from a PK/PD point of view: What do we need to know?

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.